GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Oventus Medical Ltd (ASX:OVN) » Definitions » 5-Year EBITDA Growth Rate

Oventus Medical (ASX:OVN) 5-Year EBITDA Growth Rate : 0.00% (As of Dec. 2021)


View and export this data going back to 2016. Start your Free Trial

What is Oventus Medical 5-Year EBITDA Growth Rate?

Oventus Medical's EBITDA per Share for the six months ended in Dec. 2021 was A$-0.02.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Competitive Comparison of Oventus Medical's 5-Year EBITDA Growth Rate

For the Medical Devices subindustry, Oventus Medical's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oventus Medical's 5-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Oventus Medical's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Oventus Medical's 5-Year EBITDA Growth Rate falls into.



Oventus Medical 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Oventus Medical  (ASX:OVN) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Oventus Medical 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Oventus Medical's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Oventus Medical (ASX:OVN) Business Description

Traded in Other Exchanges
N/A
Address
1 Swann Road, Suite 1, PO Box 190, Indooroopilly, Brisbane, QLD, AUS, 4068
Oventus Medical Ltd is a medical device company. It is engaged in developing an oral appliance for the treatment of sleep apnoea and snoring. Its product includes O2Vent Optima . It offers oral appliance therapy, especially beneficial for the many people that suffer from nasal congestion, obstruction, and mouth breathing. The firm has two operating segments: Australia and North America.

Oventus Medical (ASX:OVN) Headlines

No Headlines